2026-2034年全球生物银行市场规模、份额、趋势和成长分析报告

预计生物银行市场将从 2025 年的 43 亿美元成长到 2034 年的 120 亿美元，2026 年至 2034 年的复合年增长率为 12.07%。

由于科学研究和临床应用对生物样本和数据的需求不断增长，生物银行市场预计将迎来显着增长。生物样本库在支持生物医学研究中发挥着至关重要的作用，它们提供包括血液、组织和DNA样本在内的各种生物材料。随着全球对个人化医疗和基因组学的日益关注，对生物银行服务的需求不断上升，预计该市场将实现强劲成长。

此外，生物银行技术的进步正在推动市场创新。自动化样本处理、储存解决方案和资料管理系统的发展正在提高生物样本库的效率和可靠性。这些创新不仅增强了样本的完整性和可及性，还有助于与高通量定序和生物资讯学等先进调查方法的整合。随着研究不断探索生物银行的新应用领域，在研究成果的提升和合作研究机会的推动下，市场预计将进一步扩张。

此外，生物银行的格局正在发生变化，人们越来越关注伦理考量和监管合规性。随着生物样本库在样本收集和使用方面应对复杂的伦理框架和法规，对透明且合规的生物银行方法的需求预计将会成长。这一趋势在患者知情同意和资料隐私方面尤其重要，因为维护信任和透明度至关重要。随着生物银行市场的不断发展，技术进步、伦理考量以及对合作的重视将共同塑造其未来的发展轨迹。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球生物银行市场（按产品和服务划分）

• 市场分析、洞察与预测
• 设备（储存设备、样品分析设备、样品处理设备、样品运输设备）
• 耗材（储存耗材、分析耗材、处理耗材、采集耗材）
• 服务
• 软体

5. 全球生物银行市场（依样本类型划分）

• 市场分析、洞察与预测
• 血液製品
• 人体组织
• 细胞株
• 核酸
• 生物体液
• 人类粪便

6. 全球生物银行市场以储存类型划分

• 市场分析、洞察与预测
• 手动储存
• 自动储存

7. 全球生物银行市场（依所有权划分）

• 市场分析、洞察与预测
• 大学
• 国家和地区组织
• 非营利组织
• 私人组织

8. 全球生物银行市场（按应用划分）

• 市场分析、洞察与预测
• 再生医学
• 生命科学研究
• 临床研究

9. 全球生物银行市场（依最终用户划分）

• 市场分析、洞察与预测
• 製药和生物技术公司以及合约研究组织
• 学术研究机构
• 医院

第十章：全球生物银行市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十一章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十二章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck KGaA
  • Thermo Fisher ScientificInc
  • Becton, Dickinson And Company
  • PHC Holdings Corporation
  • AvantorInc
  • Greiner Holding AG
  • AzentaInc
  • Tecan Trading AG
  • Hamilton Company
  • CryoportInc
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech

The Biobanking Market size is expected to reach USD 12.00 Billion in 2034 from USD 4.30 Billion (2025) growing at a CAGR of 12.07% during 2026-2034.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
• Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products

By Storage Type

• Manual Storage
• Automated Storage

By Ownership

• Universities
• National/Regional Agencies
• Non-Profit Organizations
• Private Organizations

By Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

By End user

• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, PHC Holdings Corporation, Avantor, Inc, Greiner Holding AG, Azenta, Inc, Tecan Trading AG, Hamilton Company, Cryoport, Inc, Micronic, AMSBIO, Bay Biosciences LLC, BioKryo, SPT Labtech

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOBANKING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOBANKING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Blood Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Human Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Biological Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Human Waste Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOBANKING MARKET: BY STORAGE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Storage Type
• 6.2. Manual Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOBANKING MARKET: BY OWNERSHIP 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Ownership
• 7.2. Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. National/Regional Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Non-Profit Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOBANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Life Science Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOBANKING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Pharmaceutical & Biotechnology Companies and CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BIOBANKING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Sample Type
  • 10.2.3 By Storage Type
  • 10.2.4 By Ownership
  • 10.2.5 By Application
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Sample Type
  • 10.3.3 By Storage Type
  • 10.3.4 By Ownership
  • 10.3.5 By Application
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Sample Type
  • 10.4.3 By Storage Type
  • 10.4.4 By Ownership
  • 10.4.5 By Application
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Sample Type
  • 10.5.3 By Storage Type
  • 10.5.4 By Ownership
  • 10.5.5 By Application
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Sample Type
  • 10.6.3 By Storage Type
  • 10.6.4 By Ownership
  • 10.6.5 By Application
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BIOBANKING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Merck KGaA
  • 12.2.2 Thermo Fisher ScientificInc
  • 12.2.3 Becton, Dickinson And Company
  • 12.2.4 PHC Holdings Corporation
  • 12.2.5 AvantorInc
  • 12.2.6 Greiner Holding AG
  • 12.2.7 AzentaInc
  • 12.2.8 Tecan Trading AG
  • 12.2.9 Hamilton Company
  • 12.2.10 CryoportInc
  • 12.2.11 Micronic
  • 12.2.12 AMSBIO
  • 12.2.13 Bay Biosciences LLC
  • 12.2.14 BioKryo
  • 12.2.15 SPT Labtech